Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

taVNS + CCT for Neurocognitive Rehab

NCT: NCT07517237 · RECRUITING

NCT IDNCT07517237
StatusRECRUITING
Start Date2026-03-12
Completion2026-09-15

Brief Summary

The purpose of this study is to investigate whether combining transcutaneous auricular vagus nerve stimulation (taVNS) with computerized cognitive training might help improve thinking abilities and mood. Participants will self-administer these treatment in their homes and undergo pre- and post-treatment assessments of thinking abilities and mood and brain MRIs.

Frequently Asked Questions

What is taVNS + CCT for Neurocognitive Rehab?

taVNS + CCT for Neurocognitive Rehab is a clinical trial registered under NCT07517237. Current status: RECRUITING.

What is the status of NCT07517237?

The current status of NCT07517237 (taVNS + CCT for Neurocognitive Rehab) is: RECRUITING.

When did taVNS + CCT for Neurocognitive Rehab start?

taVNS + CCT for Neurocognitive Rehab started on 2026-03-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑